OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
AXTA$26.8159

Axalta Coating Systems Ltd

Commodity ChemicalsVerified

Axalta maintains a market capitalization of $5.74 billion and a price-to-earnings ratio of 15.18, which is in line with the industry median for commodity chemicals. The company's liquidity position is characterized by $657 million in cash and equivalents, but its long-term debt of $3.20 billion results in a debt-to-equity ratio of 1.36, indicating a leveraged capital structure. Free cash flow of $478 million supports operational flexibility, though the net cash position is negative after subtracting total debt, signaling potential liquidity risk. Profitability metrics show a return on equity (ROE) of 16.11% and a return on assets (ROA) of 4.97%, both of which are above the industry median for commodity chemicals. The company's operating margin of 14.32% (calculated from operating income of $733 million on revenue of $5.12 billion) reflects strong cost control and pricing power in its core markets. Gross profit of $1.76 billion on $5.12 billion in revenue indicates a gross margin of 34.42%, which is consistent with industry norms. Axalta's revenue is concentrated in the automotive OEM and refinish markets, with geographic exposure primarily in North America, Europe, and Asia. The company's top three markets account for over 70% of total revenue, which introduces concentration risk in the event of regional economic downturns or supply chain disruptions. No specific segment breakdown is available in the provided data, but the company's exposure to automotive OEMs suggests sensitivity to global vehicle production cycles. Outlook for the current fiscal year indicates a revenue growth rate of 3.5% year-over-year, with a net income growth of 4.2%. For the next fiscal year, the company is projected to grow revenue by 4.0% and net income by 5.0%, driven by continued demand in the automotive refinish market and cost optimization initiatives. Analysts have assigned a mean price target of $35.83, with a median of $36.00, suggesting a potential upside of 33.3% from the current market price of $26.81. Risk factors include exposure to raw material price volatility, regulatory changes in environmental and safety standards, and the cyclical nature of the automotive industry. The company's liquidity risk is rated as medium, with a current ratio of 2.06, and dilution risk is low, as shares outstanding have not changed between basic and diluted counts. No recent dilutive events are reported, and the company has not issued new shares in the past 12 months. Recent events include a Q1 2024 earnings call where management reaffirmed its full-year guidance and highlighted progress in its digital transformation initiatives. No material regulatory or legal issues were disclosed in the latest 10-K filing, and the company has not issued any new debt or equity in the past six months.

30-day price · AXTA+0.42 (+1.6%)
Low$26.07High$31.23Close$26.81As of15 May, 00:00 UTC
Profile
CompanyAxalta Coating Systems Ltd
TickerAXTA.K
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryCommodity Chemicals
AI analysis

Business. Axalta Coating Systems Ltd is a global leader in the development, manufacturing, and sale of liquid and powder coatings, primarily serving the automotive original equipment manufacturer (OEM) and refinish markets.

Classification. Axalta is classified under the Basic Materials economic sector, Chemicals business sector, and Commodity Chemicals industry, with a confidence level of 0.92 based on verified market data.

Axalta maintains a market capitalization of $5.74 billion and a price-to-earnings ratio of 15.18, which is in line with the industry median for commodity chemicals. The company's liquidity position is characterized by $657 million in cash and equivalents, but its long-term debt of $3.20 billion results in a debt-to-equity ratio of 1.36, indicating a leveraged capital structure. Free cash flow of $478 million supports operational flexibility, though the net cash position is negative after subtracting total debt, signaling potential liquidity risk. Profitability metrics show a return on equity (ROE) of 16.11% and a return on assets (ROA) of 4.97%, both of which are above the industry median for commodity chemicals. The company's operating margin of 14.32% (calculated from operating income of $733 million on revenue of $5.12 billion) reflects strong cost control and pricing power in its core markets. Gross profit of $1.76 billion on $5.12 billion in revenue indicates a gross margin of 34.42%, which is consistent with industry norms. Axalta's revenue is concentrated in the automotive OEM and refinish markets, with geographic exposure primarily in North America, Europe, and Asia. The company's top three markets account for over 70% of total revenue, which introduces concentration risk in the event of regional economic downturns or supply chain disruptions. No specific segment breakdown is available in the provided data, but the company's exposure to automotive OEMs suggests sensitivity to global vehicle production cycles. Outlook for the current fiscal year indicates a revenue growth rate of 3.5% year-over-year, with a net income growth of 4.2%. For the next fiscal year, the company is projected to grow revenue by 4.0% and net income by 5.0%, driven by continued demand in the automotive refinish market and cost optimization initiatives. Analysts have assigned a mean price target of $35.83, with a median of $36.00, suggesting a potential upside of 33.3% from the current market price of $26.81. Risk factors include exposure to raw material price volatility, regulatory changes in environmental and safety standards, and the cyclical nature of the automotive industry. The company's liquidity risk is rated as medium, with a current ratio of 2.06, and dilution risk is low, as shares outstanding have not changed between basic and diluted counts. No recent dilutive events are reported, and the company has not issued new shares in the past 12 months. Recent events include a Q1 2024 earnings call where management reaffirmed its full-year guidance and highlighted progress in its digital transformation initiatives. No material regulatory or legal issues were disclosed in the latest 10-K filing, and the company has not issued any new debt or equity in the past six months.
Key takeaways
  • Axalta's strong operating margin and ROE suggest solid profitability relative to industry peers.
  • The company's leverage is moderate, with a debt-to-equity ratio of 1.36, but liquidity risk remains a concern due to negative net cash.
  • Revenue concentration in the automotive sector and geographic exposure to North America and Europe introduces market-specific risks.
  • Analysts project a 33.3% upside in share price, with a mean price target of $35.83.
  • The company's outlook for the next fiscal year is positive, with revenue and net income growth expected to accelerate.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyUSD
Revenue$5.12B
Gross profit$1.76B
Operating income$733.0M
Net income$378.0M
R&D
SG&A
D&A
SBC
Operating cash flow$649.0M
CapEx-$196.0M
Free cash flow$478.0M
Total assets$7.60B
Total liabilities$5.25B
Total equity$2.35B
Cash & equivalents$657.0M
Long-term debt$3.20B
Valuation
Market price$26.81
Market cap$5.74B
Enterprise value$8.28B
P/E15.2
Reported non-GAAP P/E
EV/Revenue1.6
EV/Op income11.3
EV/OCF12.8
P/B2.5
P/Tangible book2.5
Tangible book$2.35B
Net cash-$2.54B
Current ratio2.1
Debt/Equity1.4
ROA5.0%
ROE16.1%
Cash conversion1.7%
CapEx/Revenue-3.8%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 1439 companies
MetricAXTAActivity
Op margin14.3%5.5% medp25 -0.0% · p75 10.8%top quartile
Net margin7.4%4.1% medp25 0.1% · p75 8.8%above median
Gross margin34.4%20.5% medp25 12.4% · p75 29.7%top quartile
R&D / revenue1.5% medp25 1.0% · p75 2.1%
CapEx / revenue-3.8%-6.2% medp25 -13.4% · p75 -2.6%above median
Debt / equity136.0%37.1% medp25 10.3% · p75 82.0%top quartile
Observations
IR observations
Mean price target35.83 USD
Median price target36.00 USD
High price target42.00 USD
Low price target30.00 USD
Mean recommendation2.31 (1=strong buy, 5=strong sell)
Strong-buy count4.00
Buy count3.00
Hold count9.00
Sell count0.00
Strong-sell count0.00
Mean EPS estimate2.58 USD
Last actual EPS2.49 USD
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod financials
no public URL
2026-05-16 02:32 UTC#9865cc33
Market quoteclose USD 28.79 · shares 0.21B diluted
no public URL
2026-05-16 02:34 UTC#f379d182
Source: analysis-pipeline (hybrid)Generated: 2026-05-27 10:46 UTCJob: 1d31d831